These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26972261)

  • 1. The Anti-Doping Movement.
    Willick SE; Miller GD; Eichner D
    PM R; 2016 Mar; 8(3 Suppl):S125-32. PubMed ID: 26972261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half a century of challenges.
    Ljungqvist A
    Bioanalysis; 2012 Jul; 4(13):1531-3. PubMed ID: 22831467
    [No Abstract]   [Full Text] [Related]  

  • 4. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lance Armstrong saga: a wake-up call for drug reform in sports.
    Sparling PB
    Curr Sports Med Rep; 2013; 12(2):53-4. PubMed ID: 23478552
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering Sports Pharmacists and Anti-Doping Education as the World Celebrates the Olympic and Paralympic Games.
    Kawaguchi-Suzuki M; Anderson A; Suzuki S
    Am J Pharm Educ; 2021 Aug; 85(7):8695. PubMed ID: 34544745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-doping analysis and the Olympics.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1529-30. PubMed ID: 22831466
    [No Abstract]   [Full Text] [Related]  

  • 9. Opinion paper: scientific, philosophical and legal consideration of doping in sports.
    Negro M; Marzullo N; Caso F; Calanni L; D'Antona G
    Eur J Appl Physiol; 2018 Apr; 118(4):729-736. PubMed ID: 29427238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical considerations in anti-doping analysis.
    Murray TH
    Bioanalysis; 2012 Jul; 4(13):1537-9. PubMed ID: 22831469
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Between medical treatment and performance enhancement: an investigation of how elite athletes experience Therapeutic Use Exemptions.
    Overbye M; Wagner U
    Int J Drug Policy; 2013 Nov; 24(6):579-88. PubMed ID: 23582632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can We Better Integrate the Role of Anti-Doping in Sports and Society? A Psychological Approach to Contemporary Value-Based Prevention.
    Petróczi A; Norman P; Brueckner S
    Med Sport Sci; 2017; 62():160-176. PubMed ID: 28571017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
    Striegel H; Rössner D; Simon P; Niess AM
    Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doping in competition or doping in sport?
    Lippi G; Franchini M; Guidi GC
    Br Med Bull; 2008; 86():95-107. PubMed ID: 18385161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicolegal aspects of doping in sports].
    Pruvost J; Depiesse F
    Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.